Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response

Ítems similars

• Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance
  per: Boeckx, Carolien, et al.
  Publicat: (2013)
• The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines
  per: Boeckx, Carolien, et al.
  Publicat: (2015)
• Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor
  per: Boeckx, Carolien, et al.
  Publicat: (2015)
• A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy
  per: Deschoolmeester, Vanessa, et al.
  Publicat: (2010)
• Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
  per: De Pauw, Ines, et al.
  Publicat: (2018)